[HTML][HTML] Uncommon EGFR mutations in a cohort of Chinese NSCLC patients and outcomes of first-line EGFR-TKIs and platinum-based chemotherapy
J Shi, H Yang, T Jiang, X Li, C Zhao… - Chinese Journal of …, 2017 - ncbi.nlm.nih.gov
… They suggested that only patients with uncommon EGFR mutations should … that NSCLC
patients harboring uncommon EGFR mutations could obtain almost equal survival through EGFR…
patients harboring uncommon EGFR mutations could obtain almost equal survival through EGFR…
EGFR tyrosine kinase inhibitor (TKI) in patients with advanced non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: A real-world study in China
J Xu, B Jin, T Chu, X Dong, H Yang, Y Zhang, D Wu… - Lung cancer, 2016 - Elsevier
… data of patients with multiple uncommon EGFR mutations and their sensitivity to EGFR TKIs.
… A total of 123 NSCLC patients harboring uncommon EGFR mutations with treatment and …
… A total of 123 NSCLC patients harboring uncommon EGFR mutations with treatment and …
A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer
HY Tu, EE Ke, JJ Yang, YL Sun, HH Yan, MY Zheng… - Lung Cancer, 2017 - Elsevier
… of uncommon EGFR mutations and their sensitivity to EGFR-TKIs… in patients with G719X and
compound L858R mutations, … of uncommon EGFR mutation in Chinese lung cancer patients …
compound L858R mutations, … of uncommon EGFR mutation in Chinese lung cancer patients …
Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non-small cell lung cancer patients
K Chen, X Yu, H Wang, Z Huang, Y Xu, L Gong… - Cancer Chemotherapy …, 2017 - Springer
… the sensitivity of uncommon EGFR mutations to TKIs therapy in a Chinese cohort of advanced
NSCLC patients. The results were discovered in a subset of NSCLC patients, which could …
NSCLC patients. The results were discovered in a subset of NSCLC patients, which could …
Next-generation sequencing reveals high uncommon EGFR mutations and tumour mutation burden in a subgroup of lung cancer patients
G Guo, G Li, Y Liu, H Li, Q Guo, J Liu, X Yang… - Frontiers in …, 2021 - frontiersin.org
… The genomic features of this cohort were compared with those of a reference Chinese
NSCLC cohort (1,802 patients, excluding patients from Xuanwei) and data from The Cancer …
NSCLC cohort (1,802 patients, excluding patients from Xuanwei) and data from The Cancer …
Identification of the Unique Clinical and Genetic Features of Chinese Lung Cancer Patients With EGFR Germline Mutations in a Large-Scale Retrospective Study
X Lin, M Peng, Q Chen, M Yuan, R Chen… - Frontiers in …, 2021 - frontiersin.org
… Somatic EGFR mutation rate in our study was 51.6%, similar to the 50.2% reported by the …
Chinese patients with lung cancer harbored unique and dispersive EGFR germline mutations, …
Chinese patients with lung cancer harbored unique and dispersive EGFR germline mutations, …
The effectiveness of afatinib and osimertinib in a Chinese patient with advanced lung adenocarcinoma harboring a rare triple EGFR mutation (R670W/H835L/L833V) …
BD Qin, XD Jiao, LY Yuan, K Liu, Z Wang… - OncoTargets and …, 2018 - Taylor & Francis
… by Frega reported a patient with NSCLC harboring a rare triple EGFR mutation. Citation7
Our patient is the first Chinese patient to have this uncommon triple EGFR mutation (L833V, …
Our patient is the first Chinese patient to have this uncommon triple EGFR mutation (L833V, …
Characterization of common and rare mutations in EGFR and associated clinicopathological features in a large population of Chinese patients with lung cancer
B Wei, P Ren, C Zhang, Z Wang, B Dong… - … -Research and Practice, 2017 - Elsevier
… EGFR mutations. To address the issue, we studied a cohort of 456 Chinese lung cancer
patients retrospectively, determined the prevalence of both common and rare EGFR mutations, …
patients retrospectively, determined the prevalence of both common and rare EGFR mutations, …
[HTML][HTML] Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment
T Zhang, B Wan, Y Zhao, C Li, H Liu, T Lv… - … lung cancer research, 2019 - ncbi.nlm.nih.gov
… In China, it is also the most common cancer … in NSCLC patients with uncommon EGFR
mutations (27-29). Controversy over the treatment of uncommon EGFR mutation-positive patients …
mutations (27-29). Controversy over the treatment of uncommon EGFR mutation-positive patients …
[HTML][HTML] … and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations
Y Zhang, Z Wang, X Hao, X Hu, H Wang… - Chinese Journal of …, 2017 - ncbi.nlm.nih.gov
… NSCLC patients with uncommon EGFR mutations diagnosed in the Department of Pathology,
National Cancer Center/Cancer Hospital, Chinese … that uncommon EGFR mutations were …
National Cancer Center/Cancer Hospital, Chinese … that uncommon EGFR mutations were …
相关搜索
- cell lung cancer uncommon egfr mutations
- tyrosine kinase inhibitors uncommon egfr mutations
- chinese nsclc patients egfr tkis
- common and rare egfr mutations
- rare egfr mutations distinct epidemiology
- post hoc analysis uncommon egfr mutations
- clinical outcomes uncommon egfr mutations
- afatinib in a patient rare egfr
- cohort study uncommon egfr mutations
- egfr mutations asian patients
- triple egfr mutations pulmonary adenocarcinoma
- epidermal growth factor receptor egfr mutations
- rare egfr mutations clinical consequence
- lung adenocarcinomas uncommon egfr mutations
- real world study uncommon egfr mutations
- real world data uncommon egfr mutations